Caricamento...
Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression?
Liver transplantation (LT) has originally been designed to treat hepatobiliary malignancies. The initial results of LT for hepatocellular cancer (HCC) were, however, dismal this mainly due to the poor patient selection procedure. Better surgical and perioperative care and, especially, the refinement...
Salvato in:
| Pubblicato in: | Transl Gastroenterol Hepatol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5676205/ https://ncbi.nlm.nih.gov/pubmed/29167827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2017.09.06 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|